drugset / Trial / NCT00179257

The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram

NCT00179257

Phase 3 Completed 20 enrolled Vanderbilt University Pfizer · collab
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this is to determine the efficacy, safety, and tolerability of sertraline in patients with major depressive disorder (MDD) who have shown inadequate response ot escitalopram.

Timeline

Start
2004-06
Primary completion
Completion
2005-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule